Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
|ClinicalTrials.gov Identifier: NCT00423826|
Expanded Access Status : No longer available
First Posted : January 18, 2007
Last Update Posted : February 29, 2016
|First Submitted Date||January 16, 2007|
|First Posted Date||January 18, 2007|
|Last Update Posted Date||February 29, 2016|
|Brief Title||Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease|
RATIONALE: Giving low doses of chemotherapy and total-body irradiation before a donor umbilical cord blood stem cell transplant helps stop the growth of cancer or abnormal cells. It also stops the patient's immune system from rejecting the donor's stem cells. The donated stem cells may replace the patient's immune cells and help destroy any remaining cancer or abnormal cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body's normal cells. Giving tacrolimus and mycophenolate mofetil before the transplant may stop this from happening.
PURPOSE: This clinical trial is studying how well umbilical cord blood stem cell transplant works in treating patients with hematologic cancer or other disease.
OUTLINE: This is a pilot study.
PROJECTED ACCRUAL: A total of 30 patients will be accrued for this study.
|Study Type||Expanded Access|
|Publications *||Not Provided|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Expanded Access Status||No longer available|
|Contacts||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries||United States|
|Removed Location Countries|
|Responsible Party||Voravit Ratanatharathorn, Barbara Ann Karmanos Cancer Institute|
|Study Sponsor||Barbara Ann Karmanos Cancer Institute|
|Collaborators||National Cancer Institute (NCI)|
|PRS Account||Barbara Ann Karmanos Cancer Institute|
|Verification Date||February 2016|